Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Modelling of individual pharmacokinetics for computer-aided drug dosage.

× No keyword cloud information.

104 in total

1. Robust optimal design for the estimation of hyperparameters in population pharmacokinetics.

Authors: M Tod; F Mentré; Y Merlé; A Mallet
Journal: J Pharmacokinet Biopharm Date: 1998-12

2. Dynamic conditionally linear mixed models for longitudinal data.

Authors: M Pourahmadi; M J Daniels
Journal: Biometrics Date: 2002-03 Impact factor: 2.571

3. Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses.

Authors: J R Koup; D J Greenblatt; W J Jusko; T W Smith; J Koch-Weser
Journal: J Pharmacokinet Biopharm Date: 1975-06

Review 4. Interpreting population pharmacokinetic-pharmacodynamic analyses - a clinical viewpoint.

Authors: Stephen B Duffull; Daniel F B Wright; Helen R Winter
Journal: Br J Clin Pharmacol Date: 2011-06 Impact factor: 4.335

Review 5. An oracle: antituberculosis pharmacokinetics-pharmacodynamics, clinical correlation, and clinical trial simulations to predict the future.

Authors: Jotam Pasipanodya; Tawanda Gumbo
Journal: Antimicrob Agents Chemother Date: 2010-10-11 Impact factor: 5.191

Review 6. Clinical mycophenolic acid monitoring in liver transplant recipients.

Authors: Hao Chen; Bing Chen
Journal: World J Gastroenterol Date: 2014-08-21 Impact factor: 5.742

Review 7. Non-linear mixed effects modeling - from methodology and software development to driving implementation in drug development science.

Authors: Goonaseelan Colin Pillai; France Mentré; Jean-Louis Steimer
Journal: J Pharmacokinet Pharmacodyn Date: 2005-11-07 Impact factor: 2.745

8. Rapid prediction of individual dosage requirements for lignocaine.

Authors: S Vozeh; M Berger; M Wenk; R Ritz; F Follath
Journal: Clin Pharmacokinet Date: 1984 Jul-Aug Impact factor: 6.447

9. Identification of patients with impaired hepatic drug metabolism using a limited sampling procedure for estimation of phenazone (antipyrine) pharmacokinetic parameters.

Authors: D Fabre; F Bressolle; R Goméni; O Bouvet; A Dubois; C Raffanel; J C Gris; M Galtier
Journal: Clin Pharmacokinet Date: 1993-04 Impact factor: 6.447

10. New susceptibility breakpoints for first-line antituberculosis drugs based on antimicrobial pharmacokinetic/pharmacodynamic science and population pharmacokinetic variability.

Authors: Tawanda Gumbo
Journal: Antimicrob Agents Chemother Date: 2010-01-19 Impact factor: 5.191